Patient-derived tumour xenografts as models for oncology drug development

被引：0
|
作者：
John J. Tentler
Aik Choon Tan
Colin D. Weekes
Antonio Jimeno
Stephen Leong
Todd M. Pitts
John J. Arcaroli
Wells A. Messersmith
S. Gail Eckhardt
机构：
[1] School of Medicine,Division of Medical Oncology, Department of Medicine
[2] University of Colorado,undefined
来源：
Nature Reviews Clinical Oncology | 2012年 / 9卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In this Review, Tentler et al. present the opportunities and challenges of using patient-derived tumour xenograft models in oncology drug development, provide specific disease examples, and describe concepts regarding predictive biomarker development and future applications.
引用
收藏
页码：338 / 350
页数：12
相关论文
共 50 条
  • [31] Preclinical models for translational immuno-oncology research: Rare patient-derived xenografts on humanized mice
    Stecklum, Maria
    Wulf-Goldenberg, Annika
    Brzezicha, Bernadette
    Walther, Wolfgang
    Hoffmann, Jens
    CANCER RESEARCH, 2023, 83 (07)
  • [32] The promises and challenges of patient-derived tumor organoids in drug development and precision oncology
    Granat, Lauren M.
    Kambhampati, Ooha
    Klosek, Stephanie
    Niedzwecki, Brian
    Parsa, Kian
    Zhang, Dong
    ANIMAL MODELS AND EXPERIMENTAL MEDICINE, 2019, 2 (03) : 150 - 161
  • [33] The promises and challenges of patient-derived tumor organoids in drug development and precision oncology
    Lauren M.Granat
    Ooha Kambhampati
    Stephanie Klosek
    Brian Niedzwecki
    Kian Parsa
    Dong Zhang
    Animal Models and Experimental Medicine, 2019, 2 (03) : 150 - 161
  • [34] Patient-derived xenografts as in vivo models for research in urological malignancies
    Takahiro Inoue
    Naoki Terada
    Takashi Kobayashi
    Osamu Ogawa
    Nature Reviews Urology, 2017, 14 : 267 - 283
  • [35] Patient-derived xenografts as in vivo models for research in urological malignancies
    Inoue, Takahiro
    Terada, Naoki
    Kobayashi, Takashi
    Ogawa, Osamu
    NATURE REVIEWS UROLOGY, 2017, 14 (05) : 267 - +
  • [36] Patient-derived organoids in translational oncology and drug screening
    Yang, Ruixin
    Yu, Yingyan
    CANCER LETTERS, 2023, 562
  • [37] PATIENT-DERIVED BRAIN TUMOUR IPSCS: MODELS FOR INVESTIGATING GLIOMA STEMNESS AND DRUG DISCOVERY
    Mathew, Ryan
    da Silva, Barbara
    Polson, Euan
    Williams, Jennifer
    Tams, Daniel
    O'Shea, Orla
    Taylor, Claire
    Shaw, Gary
    Ballereau, Stephane
    Short, Susan
    Smith, Christian
    Rutka, James
    Chumas, Paul
    Markowetz, Florian
    Wurdak, Heiko
    NEURO-ONCOLOGY, 2018, 20 : 273 - 274
  • [38] The ongoing trends of patient-derived xenograft models in oncology
    Zhuo, Jianyong
    Su, Renyi
    Tan, Winyen
    Lian, Zhengxing
    Lu, Di
    Xu, Xiao
    CANCER COMMUNICATIONS, 2020, 40 (11) : 559 - 563
  • [39] Role of Patient-Derived Models of Cancer in Translational Oncology
    Idrisova, K. F.
    Simon, H. -U.
    Gomzikova, M. O.
    CANCERS, 2023, 15 (01)
  • [40] Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics
    Guilhamon, Paul
    Butcher, Lee M.
    Presneau, Nadege
    Wilson, Gareth A.
    Feber, Andrew
    Paul, Dirk S.
    Scuette, Moritz
    Haybaeck, Johannes
    Keilholz, Ulrich
    Hoffman, Jens
    Ross, Mark T.
    Flanagan, Adrienne M.
    Beck, Stephan
    GENOME MEDICINE, 2014, 6
12345